Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in
Home>News>This Article

Xcelience® Celebrates 25% Growth in 2013

Published: Monday, September 23, 2013
Last Updated: Sunday, September 22, 2013
Bookmark and Share
Company adds team members.

Xcelience has announced the completion of a milestone 25 percent increase in staff since September of 2012, growing from 85 team members then to 113.

“We’re going through a period of robust growth,” says Derek Hennecke, CEO and President. “We’ve added team members to Formulation, Preformulation and Analytical, as well as growing our new Clinical Supply Services (CSS) division. We’re also exploring new growth in commercial development with three projects on track to produce registration batches next year.”

“Most of our new employees were recruited from a strong pool of candidates here in Tampa, but we also bring talent from New Jersey, Connecticut and other states,” Hennecke says.

Hennecke continued, “The 28 new team members we’ve added in the last year have brought fresh ideas and new efficiencies to the business. As CEO I’ve learned that the best thing I can do is hire top talent and then get out of their way.”

Many of the new employees work in the company’s CSS facility located on Grace Street in Tampa, which celebrated the grand opening with a ribbon-cutting ceremony in September 2012.

“CSS has now produced well over one hundred batches and introduced a new blister and bottling line in January of this year,” says Hennecke.

“I can’t tell you how exciting it has been to show clients and potential clients our CSS capabilities and services,” says Clinical Packaging Manager, Damian Gant. “We are the only CDMO specifically targeting the clinical supplies market with a small-scale flexible service. Other companies have tried to scale down large production facilities to produce for this market, but scaling down is a bit like driving an RV to work. A large company can do the job, but it’s expensive, inflexible, inefficient, and frankly, not cut out for the job.”

“Xcelience is the only American CDMO under $2 billion in revenue that has created an entire division devoted specifically to clinical trial clients with their small runs and highly flexible production and distribution needs,” Gant adds. “The growth potential within this market is tremendous.”

Xcelience’s Formulation and Manufacturing divisions also celebrated a landmark this year, with the production of Xcelience’s four millionth Xcelodose capsule. This accomplishment cements the company’s position as an industry leader in the expertise of precision API micro-dosing.

Xcelience was the first CDMO to introduce the Xcelodose into the United States in 2005 and now operates five machines, most of which can produce upwards of 66,000 capsules per month.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Xcelience to Expand Headquarter Operations in Tampa
International pharmaceutical development and manufacturing company will create 100 new jobs, capital investment of more than $9 million.
Friday, March 20, 2015
Scientific News
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
NIH-funded study suggests therapeutic window may extend to later-stage disease.
Treatment for Rare Bleeding Disorder is Effective
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
HIV Vaccine Human Trials Begin
Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Scroll Up
Scroll Down

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos